Thursday, October 11, 2012
Publication and contact
Alzheimer's disease (AD)
Epidermal growth factor receptor (EGFR)
Drosophila and mouse studies suggest EGFR inhibitors could
help treat AD. In transgenic flies expressing human b-amyloid 42,
the EGFR inhibitors Iressa
prevented memory loss as effectively as the approved AD drug memantine.
In a transgenic mouse model of AD, Iressa decreased memory loss compared with
vehicle. In both a mouse and fly behavioral screen of 2,000 synthetic
compounds that modulate protein kinase activities,
3 compounds prevented memory loss and inhibited b-amyloid
mediated Egfr activity. Next steps include identifying more compounds for
Pharma Inc., Chugai
Pharmaceutical Co. Ltd. and Roche
market Tarceva erlotinib to treat pancreatic cancer
and non-small cell lung cancer (NSCLC).
plc's Iressa is in Phase III testing to treat head and neck
Published online Oct. 11, 2012
Patent application filed;
available for licensing
Wang, L. et al. Proc.
Natl. Acad. Sci. USA; published online Sept. 27, 2012;
Contact: Yi Zhong, Cold Spring Harbor Laboratory, Cold
Spring Harbor, N.Y.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]